Default company panoramic image
Femselect 20  20color 20 tall

FEMSelect Ltd. (formerly POP Medical Solutions Ltd.)

FEMSelect (formerly POP Medical) developed EnPlace, a minimally invasive, mesh-free approach to prolapse repair. Standard of care is complex & invasive surgery.

  • Stage $1M in TTM Revenue
  • Industry Medical Devices and Equipment
  • Location Tel Aviv Region, Israel
  • Currency USD
  • Founded December 2012
  • Employees 5
  • Incorporation Type C-corp
  • Website femselect.com

Company Summary

FEMSelect developed EnPlace – a minimally invasive, mesh-free approach to prolapse repair that has FDA clearance and CE Mark. Women experience minimal pain & recover in days. Standard of care is complex and invasive surgery in a $10B global market. FEMSelect has begun selling the disposable device in Israel and in the US with its US partner, LiNA Medical USA, and is raising a Round B to expand US commercialization.